Topics
ONE TIME EVENT
Advancing mCRC Treatment: Integrating Biomarker Testing, ESMO 2022 Guidelines, and Anti-eGFR Therapies
ONE TIME EVENT
Chance for Cure in CD30+ Lymphomas: Improving Outcomes in HL
ONE TIME EVENT
mCRC Boot Camp for Oncologists
ONE TIME EVENT
Narrowing the Gap in DLBCL: Updates in new treatment options
ONE TIME EVENT
Brentuximab Vedotin: Finding a Chance for Cure in Peripheral T-cell Lymphoma and other CD30+ Lymphomas